Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants

NCT01204658 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

576

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Streptococcal

Interventions

BIOLOGICAL: Pneumococcal vaccine GSK 2189242A (LD formulation 1)
BIOLOGICAL: Pneumococcal vaccine GSK 2189242A (HD formulation 2)
BIOLOGICAL: Synflorix
BIOLOGICAL: Prevenar 13
BIOLOGICAL: Infanrix Hexa (DTPa-HBV-IPV/Hib)

Sponsor

GlaxoSmithKline